Pfizer possesses several qualities that make it attractive when market volatility is high. The stock has a low forward earnings multiple and a higher -- yet still attractive -- EV-to-EBITDA ratio.
The Global Generic Drugs Market, valued at USD 487.21 Billion in 2024, is poised to reach USD 898 Billion by 2035, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback